Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland

Greenebaum Cancer Center, University of Maryland is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Greenebaum Cancer Center, University of Maryland has participated in 2 clinical trials.

Therapeutic areas: Multiple Myeloma, B-lymphoid Malignancies, Chronic Lymphocytic Leukemia.

Sponsors: Adaptimmune, Sunesis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenebaum Cancer Center, University of Maryland?

Greenebaum Cancer Center, University of Maryland has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenebaum Cancer Center, University of Maryland conducted?

Greenebaum Cancer Center, University of Maryland has 2 clinical trials on record. Their work covers Multiple Myeloma, B-lymphoid Malignancies, Chronic Lymphocytic Leukemia.

Is Greenebaum Cancer Center, University of Maryland accredited by Crixeo Health?

Greenebaum Cancer Center, University of Maryland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenebaum Cancer Center, University of Maryland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.